Pemphigoid Gestationis Refractive to Dual Systemic Therapy Treated With Dupilumab
Key Points
Dupilumab treatment led to significant improvement in symptoms of pemphigoid gestationis, indicating its effectiveness.
The case demonstrates a favorable outcome after dual systemic therapy had proven ineffective for the patient.
Assessment involved individual patient history and clinical observations over the course of treatment.
Dupilumab's role signals a shift in treatment strategies, requiring further exploration in broader populations.
Abstract
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.